Navigation Links
Opioids for chronic pain: Study looks at how patients and their doctors talk about risks
Date:10/22/2013

INDIANAPOLIS -- Although the popular press -- from entertainment news to the crime blotter -- has paid significant attention to the dangers of hydrocodone, oxycodone and other opioids, little is known about whether and how this issue comes up in discussions between chronic pain patients and their physicians.

A pilot study by researchers from the Roudebush VA Medical Center and the Regenstrief Institute is believed to be the first to analyze the nature of these conversations in regular primary care appointments. A better understanding of how patients and doctors discuss these potentially addictive pain medications may ultimately lead to more effective strategies for communicating about chronic pain treatment.

'''I'm Not Abusing or Anything': Patient-physician communication about opioid treatment in chronic pain" is published in the November issue of Patient Education and Counseling, the official journal of the American Academy on Communication in Healthcare and of the European Association for Communication in Healthcare.

The study followed 30 patients with chronic pain. They were audio-recorded during visits with their primary care doctor and then interviewed about their pain care as well as their relationship with their physicians.

"Chronic pain -- pain lasting more than six months -- is a debilitating problem for many individuals," said study first author Regenstrief Institute investigator Marianne S. Matthias, Ph.D., a VA research scientist and an adjunct assistant professor of communication studies in the School of Liberal Arts at Indiana University-Purdue University Indianapolis. "Although it is well established that opioid treatment for chronic pain poses numerous uncertainties, little has been reported in previous studies about how patients and their physicians actually discuss these uncertainties in clinic appointments.

"Our study provides a window into how uncertainty about potential addiction and misuse of opioids is managed through patient-physician communication. We heard candid discussions revealing concern by both patients and their physicians about a range of issues including past alcoholism and past marijuana or cocaine use.

"There is an important message here for people with chronic pain and for the doctors who treat them. If patients and their doctors have a relationship marked by mutual trust and a strong therapeutic alliance, they are better positioned to candidly discuss all chronic pain treatment options, including risks and benefits of opioid treatment, with the ultimate goal being to develop the most appropriate and effective treatment plan for each individual patient." said Dr. Matthias, a health services researcher and communication scientist.

Three patterns of physician responses to uncertainty about prescribing opioids were observed in the audio-recordings: reassurance, avoiding opioids and gathering additional information.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-843-2276
Indiana University
Source:Eurekalert  

Related medicine news :

1. Overprescribing of opioids impacts patient safety and public health
2. Opioids associated with highest risk of death
3. Chronic use of prescription painkillers continues following bariatric surgery
4. New Clinical Study Finds that Nutraceutical Deepak Chopra Endorphinate® Provides Effective, Safe Relief for Chronic Anxiety, Depression, Cravings & Pain Hypersensitivity
5. Chronic Wounds and High Risk Surgical Incisions Successfully Treated with Spiracur’s Ultraportable Negative Pressure Wound Therapy System
6. PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
7. Chronic aggressive behavior in boys: Epigenetic sources?
8. Rosacea Control by Forces of Nature Offers Brand-New Solution to Treat Chronic Skin Condition
9. CWRU researchers find what stresses parents with a chronically ill child
10. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
11. Predicting who will have chronic pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Opioids for chronic pain: Study looks at how patients and their doctors talk about risks
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology: